Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Assets (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Assets for 14 consecutive years, with $30.5 million as the latest value for Q4 2025.

  • Quarterly Assets fell 12.62% to $30.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.5 million through Dec 2025, down 12.62% year-over-year, with the annual reading at $30.5 million for FY2025, 12.62% down from the prior year.
  • Assets hit $30.5 million in Q4 2025 for STRATA Skin Sciences, down from $30.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $55.2 million in Q2 2023 to a low of $29.5 million in Q2 2025.
  • Historically, Assets has averaged $43.4 million across 5 years, with a median of $45.4 million in 2021.
  • Biggest five-year swings in Assets: rose 20.14% in 2022 and later decreased 29.79% in 2024.
  • Year by year, Assets stood at $46.6 million in 2021, then increased by 12.19% to $52.3 million in 2022, then fell by 19.62% to $42.0 million in 2023, then dropped by 16.87% to $34.9 million in 2024, then decreased by 12.62% to $30.5 million in 2025.
  • Business Quant data shows Assets for SSKN at $30.5 million in Q4 2025, $30.7 million in Q3 2025, and $29.5 million in Q2 2025.